Singapore markets close in 5 hours 1 minute

Straits Times Index
3,338.40
+5.60(+0.17%)
Nikkei
39,665.03
+81.95(+0.21%)
Hang Seng
17,718.61
+2.11(+0.01%)
FTSE 100
8,164.12
-15.56(-0.19%)
Bitcoin USD
63,377.04
+2,575.75(+4.24%)
CMC Crypto 200
1,313.86
+30.03(+2.34%)

VRTX Jul 2024 475.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

2.5000

-1.9800

(-44.20%)

At close: 03:47PM EDT

GuruFocus.com
Insider Sale at Vertex Pharmaceuticals Inc (VRTX): EVP and CMO Carmen Bozic Sells 2,280 Shares
The transaction was executed at a price of $471.72 per share, as detailed in the SEC Filing. Following this sale, the insider now owns 30,099 shares of Vertex Pharmaceuticals Inc. Vertex Pharmaceuticals Inc (NASDAQ:VRTX) is a biotechnology firm focused on developing and commercializing therapies for the treatment of cystic fibrosis and other severe diseases.
Zacks
Vertex (VRTX) Rises 16.5% YTD: Time to Bet On the Stock?
While CF remains the main area of focus, Vertex (VRTX) has seen rapid success in its non-CF pipeline candidates' development in the past year.
Zacks
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
Vertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.